XML 48 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Tables)
 6 Months Ended
Jan. 31, 2024
Equity [Abstract]  
Total share-based compensation expense
The following table summarizes the total share-based compensation expense that we recorded in operating income for the periods shown.
 Three Months EndedSix Months Ended
(In millions)January 31,
2024		January 31,
2023		January 31,
2024		January 31,
2023
Cost of revenue$101 $91 $202 $177 
Selling and marketing125 108 248 214 
Research and development162 132 323 268 
General and administrative87 92 197 186 
Total share-based compensation expense$475 $423 $970 $845 
Summary of share-based awards available for grant
A summary of share-based awards available for grant under our plans for the six months ended January 31, 2024 was as follows:
(Shares in thousands)Shares
Available
for Grant
Balance at July 31, 202319,026 
Additional shares authorized
12,200 
Restricted stock units granted (1)
(1,342)
Options granted— 
Share-based awards canceled/forfeited/expired (1) (2)
3,393 
Balance at January 31, 202433,277 
(1)RSUs granted from the pool of shares available for grant under our 2005 Equity Incentive Plan reduce the pool by 2.3 shares for each share granted. RSUs forfeited and returned to the pool of shares available for grant under the 2005 Equity Incentive Plan increase the pool by 2.3 shares for each share forfeited.
(2)Stock options and RSUs canceled, expired, or forfeited under our 2005 Equity Incentive Plan are returned to the pool of shares available for grant. Under the 2005 Equity Incentive Plan, shares withheld for income taxes upon vesting of RSUs that were granted on or after July 21, 2016 are also returned to the pool of shares available for grant. Stock options and RSUs canceled, expired, or forfeited under older expired plans are not returned to the pool of shares available for grant.
Summary of restricted stock unit activity
A summary of RSU and restricted stock activity for the six months ended January 31, 2024 was as follows:
(Shares in thousands)Number
of Shares
Weighted-
Average
Grant Date
Fair Value
Nonvested at July 31, 202311,894 $433.70 
Granted583 554.87 
Vested(2,030)414.77 
Forfeited(665)362.95 
Nonvested at January 31, 20249,782 $449.66 
Summary of stock option activity
A summary of stock option activity for the six months ended January 31, 2024 was as follows:
 Options Outstanding
(Shares in thousands)Number
of Shares
Weighted-
Average
Exercise
Price
Per Share
Balance at July 31, 20232,130 $360.17 
Granted— — 
Exercised(460)207.02 
Canceled or expired(100)466.02 
Balance at January 31, 20241,570 $398.28 
Exercisable at January 31, 2024855 $335.53